Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

No definitive link between finasteride and male breast cancer, but further research is needed.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Diabetes may lower the risk of prostate cancer.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Lespedeza cuneata extract may help treat enlarged prostate.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Androgens may influence bladder cancer progression by affecting cellular behavior.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.